跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,533 条关于
“bevacizumab-nwgd”
全部
3,533
临床试验
3,068
药物
90
机构
3
资讯
372
去年
FDA Approves Biocon Biologics' Bevacizumab Biosimilar JOBEVNE for Multiple Cancer Indications
去年
FDA Phases Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
去年
Biocon Reports 15% Revenue Growth in Q4FY25, Launches Fifth Biosimilar in U.S. Market
去年
Bevacizumab Shows Superior Overall Survival Compared to Aflibercept in RAS Wild-Type Metastatic Colorectal Cancer
2年前
Roche's Bevacizumab Under Evaluation for Endometrial Cancer Treatment
去年
Alternating CAPOX/CAPIRI Plus Bevacizumab Shows Promise in Metastatic Colorectal Cancer
去年
LYTENAVA Receives NICE Recommendation for Wet AMD Treatment in the UK
8个月前
NICE Approves Bevacizumab for Metastatic Colorectal Cancer Following Biosimilar Availability
去年
Bevacizumab Biosimilar Approval Could Eliminate Low-Cost AMD Therapy Access
去年
Bevacizumab Plus Pembrolizumab Shows Promise in Platinum-Resistant Nasopharyngeal Cancer
第 1 页,共 38 页
上一页
下一页